Prioritized, Consolidated Health Claims Petitions Requested By FDA’s Levitt
This article was originally published in The Tan Sheet
Executive Summary
Anticipating an influx of health claims petitions now that less stringent approval standards are in the works, FDA is urging industry to consider limits on the number of submissions